Genequest, a DNA testing spin-out of the University of Tokyo, is about to open its doors to the general public. For a fee of $493, customers will be able to submit saliva swabs for DNA testing, with an eye to identify genetic risks, such as the likelihood of cancer, diabetes, or other diseases. The tests…
Tokyo sees DNA’s commercial side
Dec 2, 2013 •
LEADERSHIP SOCIETYInforming, connecting, and transforming the global corporate venture capital ecosystem.
The Global Corporate Venturing (GCV) Leadership Society’s mission is to help bridge the different strengths and ambitions of investors across industry sectors, geography, structure, and their returns.
More featured content
Resistance is futile: seven superconductor companies that want to change the world
From healthcare to fusion to quantum computing to space, superconductors have the potential to revolutionise the world. And the technology is finally ready to commercialise.
UK universities urged to lower spinout stakes
A new report recommends stakes of less than 25% but fails to address the issue of access to early-stage capital.
Dec 14, 2023
Mar 14, 2024
Monterey, CA (USA)
Jun 26, 2024